Corbus Pharmaceuticals Holdings shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised its price target from $77 to $82.
Portfolio Pulse from Benzinga Newsdesk
Corbus Pharmaceuticals Holdings shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised its price target from $77 to $82.
June 11, 2024 | 4:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Corbus Pharmaceuticals Holdings shares are trading higher after RBC Capital maintained an Outperform rating on the stock and raised its price target from $77 to $82.
The increase in price target and the maintained Outperform rating by RBC Capital are positive signals for investors, likely leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100